Q4 2018

Source filing unavailable

Q4 2018 · —

derived · Computed from the longer spans the company filed.

Revenue

$4.94M

derivedno prior Q4 2017 on file

Net Income

-$15.44M

derivedno prior Q4 2017 on file

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Incomederived-$16,105,000—

Same quarter

no prior Q4 2017 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Precision Biosciences Inc · CIK 1357874 · Engraved from SEC EDGAR